Updated: February 2, 2026
Vemlidy Side Effects: What to Expect and When to Call Your Doctor
Author
Peter Daggett

Summarize with AI
Most Vemlidy side effects are mild, but some require immediate attention. Here's a complete guide to what to expect — from common effects like headache to serious warnings like lactic acidosis.
Vemlidy (tenofovir alafenamide, or TAF) is generally well tolerated — one of the reasons it's recommended as a first-line treatment for chronic hepatitis B by leading liver disease organizations. But like all medications, it can cause side effects ranging from mild and manageable to serious and requiring immediate medical attention. Here's what you need to know.
Boxed Warnings: The Most Serious Risks
The FDA requires Vemlidy to carry a boxed warning — the most serious safety notice the agency issues — about two life-threatening risks:
Post-treatment severe acute exacerbation of hepatitis B: If you stop Vemlidy — even for a short time — the hepatitis B virus can rebound rapidly and cause severe liver inflammation. This can progress to liver failure. Never stop Vemlidy without talking to your doctor first.
Lactic acidosis and severe hepatomegaly with steatosis: Fatal cases have been reported with nucleoside analogs including tenofovir products. If you develop unusual fatigue, weakness, nausea, stomach pain, or difficulty breathing while on Vemlidy, contact your doctor or go to the emergency room immediately.
Common Side Effects (Occurring in ≥10% of Patients)
The most common side effect reported in clinical trials is headache, which occurred in at least 10% of patients. Other commonly reported side effects in adult and pediatric trials include:
Headache — the most frequently reported side effect in adult clinical trials
Nausea — taking Vemlidy with food (required) usually reduces nausea
Fatigue — tiredness that may improve as your body adjusts to the medication
Cough — reported more often in adults taking Vemlidy than placebo or TDF
Abdominal pain — stomach discomfort, often mild; taking with food helps
Diarrhea — particularly noted in pediatric trials
Nasopharyngitis — cold-like symptoms (runny nose, congestion), reported in pediatric clinical trials
Serious Side Effects: When to Seek Immediate Medical Attention
The following symptoms may signal serious complications. Stop taking Vemlidy and seek emergency care or call your doctor immediately if you experience:
Unusual muscle pain, weakness, or numbness (possible lactic acidosis)
Trouble breathing or shortness of breath (possible lactic acidosis)
Stomach pain with nausea or vomiting (possible hepatomegaly/lactic acidosis)
Yellowing of skin or eyes (jaundice — possible liver problems)
Change in the amount or color of urine (possible kidney problems)
Bone pain or fractures (possible Fanconi syndrome or bone density loss)
Severe depression, anxiety, or mood changes (mental/mood changes warrant prompt evaluation)
Kidney and Bone Safety: Vemlidy vs. Older Tenofovir Drugs
One of the key reasons Vemlidy was developed is that its predecessor, tenofovir disoproxil fumarate (TDF/Viread), can cause kidney damage and bone mineral density loss with long-term use. Vemlidy delivers tenofovir more efficiently to liver cells at a 10x lower dose, resulting in much lower blood concentrations — and therefore less exposure to kidneys and bones.
However, kidney problems have still been reported with Vemlidy post-marketing, including:
Acute renal failure
Proximal renal tubulopathy (PRT)
Fanconi syndrome
Your doctor will monitor your kidney function (serum creatinine, eGFR, urine protein/glucose) at regular intervals while you take Vemlidy.
Weight Gain
Greater weight gain has been reported with TAF compared to TDF in adult studies. If you notice significant unexplained weight gain while on Vemlidy, discuss it with your doctor.
Taking Vemlidy Safely: Reduce Your Side Effect Risk
Always take Vemlidy with food — food is required for proper absorption and reduces GI side effects
Stay hydrated — especially important to support kidney health
Avoid NSAIDs (ibuprofen, naproxen) unless directed by your doctor — they can increase kidney toxicity risk with tenofovir products
Don't stop Vemlidy without medical advice — this is the most important safety rule for hepatitis B patients
For more about medications that can interact with Vemlidy and worsen side effects, see: Vemlidy Drug Interactions: What to Avoid and What to Tell Your Doctor.
Frequently Asked Questions
The most common side effect of Vemlidy is headache (reported in at least 10% of patients). Other common side effects include nausea, fatigue, cough, abdominal pain, and diarrhea. Most of these are mild and often improve over time or with taking Vemlidy with food.
Vemlidy has significantly less kidney impact than its predecessor TDF (Viread) because it delivers tenofovir more directly to liver cells at a 10x lower dose. However, kidney problems including acute renal failure, proximal renal tubulopathy, and Fanconi syndrome have been reported post-marketing. Your doctor will monitor kidney function regularly while you take Vemlidy.
Serious side effects include lactic acidosis (build-up of lactic acid in the blood), severe hepatomegaly with steatosis (fatty liver with inflammation), kidney impairment, and Fanconi syndrome. Symptoms to watch for: unusual muscle weakness, difficulty breathing, stomach pain, jaundice, or changes in urination. Seek immediate medical attention if these occur.
Stopping Vemlidy suddenly can cause a severe and potentially life-threatening flare-up of hepatitis B, as listed in the drug's boxed warning. Liver function should be monitored closely for at least several months after stopping. Never discontinue Vemlidy without consulting your doctor first.
Caution is advised. NSAIDs like ibuprofen and naproxen can increase the risk of kidney toxicity in combination with tenofovir products including Vemlidy. Occasional low-dose use may be acceptable, but regular or high-dose NSAID use should be discussed with your doctor. Acetaminophen (Tylenol) may be a safer alternative for pain relief.
Medfinder Editorial Standards
Medfinder's mission is to ensure every patient gets access to the medications they need. We are committed to providing trustworthy, evidence-based information to help you make informed health decisions.
Read our editorial standardsPatients searching for Vemlidy also looked for:
More about Vemlidy
31,357 have already found their meds with Medfinder.
Start your search today.





